GURUFOCUS.COM » STOCK LIST » Real Estate » REITs » Global Medical REIT Inc (STU:3UN) » Definitions » Research & Development

Global Medical REIT (STU:3UN) Research & Development : €0.0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Global Medical REIT Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Global Medical REIT's Research & Development for the three months ended in Dec. 2024 was €0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was €0.0 Mil.


Global Medical REIT Research & Development Historical Data

The historical data trend for Global Medical REIT's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Global Medical REIT Research & Development Chart

Global Medical REIT Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Global Medical REIT Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Global Medical REIT Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Global Medical REIT  (STU:3UN) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Global Medical REIT Research & Development Related Terms

Thank you for viewing the detailed overview of Global Medical REIT's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Global Medical REIT Business Description

Traded in Other Exchanges
Address
7373 Wisconsin Avenue, Suite 800, Bethesda, MD, USA, 20814
Global Medical REIT Inc is engaged predominantly in the acquisition of purpose-built healthcare facilities and the leasing of those facilities to physician groups and regional and national healthcare systems. The company's principal business objective is to provide attractive, risk-adjusted returns to its stockholders through a combination of reliable dividends and long-term capital appreciation. Its healthcare facilities are located in secondary markets and suburbs of primary markets and are typically leased to single-tenants under triple-net leases.

Global Medical REIT Headlines

No Headlines